The major platelet integrin IIb 3 , also known as the platelet glycoprotein (GP) IIbIIIa complex, mediates platelet aggregation by serving as the receptor for fibrinogen and von Willebrand factor. In addition to its physiologic role, GPIIb-IIIa also bears a number of clinically important alloantigenic determinants. Previous studies have shown that disruption of the long-range Cys 5 -Cys 435 disulfide bond of the 3 subunit results in the production of isoforms that bind some, but not all, anti-Pl A1 alloantibodies, suggesting that mutations in this so-called long-range disulfide bond can alter the conformation of GPIIIa. The purpose of this study was to examine the effects of either the Cys5Ala or Cys435Ala substitution of GPIIIa on the adhesive properties of the GPIIb-IIIa complex. We found that both Ala5GPIIIa and well as soluble fibrinogen. Both GPIIb-Ala5IIIa and GPIIb-Ala435IIIa-transfected CHO cells also bound more avidly to immobilized fibrinogen, and were capable of mediating the tyrosine phosphorylation of pp125FAK upon cell adhesion. These data are consistent with the notion that these regions of GPIIIa participate in the conformational change associated with receptor activation. Additionally, these studies may provide a molecular explanation for the previously reported ability of mild reducing agents to activate the GPIIb-IIIa complex and promote platelet aggregation. qsun@bcsew.edu
ABSTRACT
The major platelet integrin IIb 3 , also known as the platelet glycoprotein (GP) IIbIIIa complex, mediates platelet aggregation by serving as the receptor for fibrinogen and von Willebrand factor. In addition to its physiologic role, GPIIb-IIIa also bears a number of clinically important alloantigenic determinants. Previous studies have shown that disruption of the long-range Cys 5 -Cys 435 disulfide bond of the 3 subunit results in the production of isoforms that bind some, but not all, anti-Pl A1 alloantibodies, suggesting that mutations in this so-called long-range disulfide bond can alter the conformation of GPIIIa. The purpose of this study was to examine the effects of either the Cys5Ala or Cys435Ala substitution of GPIIIa on the adhesive properties of the GPIIb-IIIa complex. We found that both Ala5GPIIIa and Ala435GPIIIa were capable of associating with GPIIb and were expressed normally on the cell surface when co-transfected into Chinese Hamster Ovary (CHO) cells. CHO cells expressing GPIIb-Ala5GPIIIa or GPIIb-Ala435IIIa bound well-characterized, conformationally-sensitive LIBS (ligand-induced binding site) antibodies, and were capable of constitutively binding the fibrinogen-mimetic monoclonal antibodies PL-55 and PAC-1, as well as soluble fibrinogen. Both GPIIb-Ala5IIIa and GPIIb-Ala435IIIa-transfected CHO cells also bound more avidly to immobilized fibrinogen, and were capable of mediating the tyrosine phosphorylation of pp125FAK upon cell adhesion. These data are consistent with the notion that these regions of GPIIIa participate in the conformational change associated with receptor activation. Additionally, these studies may provide a molecular explanation for the previously reported ability of mild reducing agents to activate the GPIIb-IIIa complex and promote platelet aggregation. qsun@bcsew.edu macromolecules is tightly regulated by integrin activation or inside-out signaling, also known as affinity modulation, which involves structural changes intrinsic to the heterodimer, and avidity modulation due to lateral diffusion and clustering of heterodimers into oligomers 4; 5 .
In addition, ligand-induced binding site (LIBS) antibodies, which preferentially bind the ligand-occupied form of receptor, can lock the integrin into a higher-affinity state without the need for signals from inside the cell 6; 7 . Following receptor occupancy, information is transduced across the plasma membrane in a process termed outside-in signaling. These signals include elevation of intracellular pH and calcium, inositol lipid synthesis, and the tyrosine phosphorylation of a wide range of proteins, including focal adhesion kinase (FAK), 14 . Although all of cysteines within GPIIIa have been thought to form disulfide bonds that stabilize the overall three-dimensional structure, recent studies suggest that EGF repeats 2 and 4 may contain unpaired cysteines which exhibit the properties of a redox site involved in integrin activation 16 . In concert with these findings, GPIIIa has also been reported to contain endogenous thiol isomerase activity, predicted from the presence of the tetrapeptide motif, CXXC, in each of GPIIIa EGF repeats 17 . Disulfide exchange has been demonstrated to take place during integrin-mediated platelet adhesion and surface thiol isomerase has been implicated in this process 18 .
A Triton X-100, 2 mM PMSF, and 100 µg/ml leupeptin) for 30 min on ice 35 . The supernatant Cell adhesion assays. Cell adhesion assays were performed using vital-dye labeled cells as described previously 36 . For
RESULTS

The long-range disulfide bond between residues Cys 5 and Cys 435 of GPIIIa is disrupted by
Cys5Ala or by Cys435Ala substitution. CHO cells transfected with GPIIb and either WT, Ala5GPIIIa or Ala435GPIIIa were established. The presence of these mutations was confirmed by DNA sequence analysis ( Figure 1A) . Cys 5 and Cys 435 have been reported to form a disulfide bridge that brings the N-terminal region and EGF repeats of GPIIIa into close physical proximity 15 . Substitution of either cysteine 5 or 435 with alanine would be predicted to result in conformational change, which should be visible as a shift in the migration of GPIIIa on a non-reduced SDS-PAGE gel. As shown in Figure 1B , the WT, Ala5 and Ala435 forms of GPIIIa run with the same mobility under reducing conditions.
However, under non-reducing conditions, both Ala5GPIIIa and Ala435GPIIIa migrate more slowly than does WT GPIIIa. These data indicate that the conformation of GPIIIa has been altered by the alanine 5 or 435 mutations.
Ala5GPIIIa and Ala435GPIIIa are capable of associating with GPIIb and the integrins are
expressed normally on the cell surface. The ability of Ala435GPIIIa to associate with GPIIb is shown in Figure 2A . Both AP3 (specific for the GPIIIa subunit) and AP2 (specific for the GPIIb-IIIa complex) immunoprecipitated GPIIb-Ala435GPIIIa together, demonstrating that the formation of an integrin complex takes place. Essentially the same results were seen for the Ala5GPIIIa variant (not shown). The expression of GPIIb-Ala5GPIIIa and GPIIbAla435IIIa complexes on the cell surface was analyzed by flow cytometry using AP2 and AP3 ( Figure 2B) , and as shown, these two antibodies specifically and positively stained Figure 3A , lower middle). AP5 could not report the conformational change elicited by the Cys5Ala mutation, as its epitope (GPIIIa residues 1-6) 9 is proximal to the amino acid substitution. Similarly, the ability of D3 to bind the 435AlaGPIIIa variant is lost due to the fact that its epitope is near residue 422 of GPIIIa 37 . However, the binding of non-LIBS antibody, AP3, which mapped within the residues 348-421 of GPIIIa, was not affected by Cys435Ala substitution (Figure 2B) . The activation index of other LIBS antibodies is summarized in Figure 3B . Taken together, these GPIIIa contains 56 cysteines, seven of which are located within the still-to-bevisualized PSI domain, four within the A domain, four within the Ig-like "hybrid" domain, three within the flexible "Linker 2" region immediately upstream of the first cysteine-rich EGF repeat, 30 within the four EGF repeats themselves, and eight within the -terminal domain ( -TD) 14 . Of these, 32 cysteines can be visualized, and all of these are paired.
Since EGF repeats are exceedingly well-conserved, an additional seven disulfide bonds located within EGF-1 and EGF-2 (not directly visualized due to likely mobility of this segment within the crystal) can be assigned with relative confidence, leaving only 10
unaccounted-for cysteines -seven within the disordered PSI domain, and three within Linker 2 (residues 435-452). Cys 5 and Cys 435 are found within the PSI and Linker 2 regions, respectively, and if paired as proposed 15 , would serve to bring into close apposition these two linearly distant regions of GPIIIa. Since Cys Ala mutations in either of these residues have similar effects on complex formation, surface expression, and cell adhesion, our studies provide functional evidence that a long-range disulfide bond between Cys 5 -Cys 435 may indeed exist.
In platelet functional assays, it has been previously shown that treatment of platelets with the reducing agent dithiothreitol induces platelet aggregation, fibrinogen binding, and
GPIIb-IIIa conformational changes 38; 39 . Similar changes have been observed in other integrins 40 .
The studies reported here demonstrate that genetic disruption of Cys 5 -Cys 435 is sufficient to activate the complex. Interestingly, disruption of other disulfide bonds near or within the cysteine-rich EGF repeat region of the molecule, including those at Cys 598 23 and
Cys 560 41 also seem to preferentially activate the GPIIb-IIIa complex. Integrin activation as a result of alterations within the EGF domains does not appear to be restricted to mutations involving cysteine residues, as Kashiwagi et al 22 have shown that Thr562Asn mutation at the boundary of EGF-3 and EGF-4 also results in production of a constitutively-active complex.
Taken together, these data suggest the intriguing possibility that the EGF-repeats of the molecule may be intimately involved in the conformational switch that controls receptor
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From activation. Mutations outside of this region, even to cysteine residues, do not appear to affect the activation state of the complex, as previously shown by Wang et al. 42 for Cys 655 , which lies within the C-terminal -TD. Structural studies on the effects of perturbations of the EGF domains on integrin activation are necessary, however, before their role in controlling the conformation of the complex can be established with certainty.
In addition to their physiological role, both GPIIb and GPIIIa are known to bear a number of clinically important alloantigenic determinants, such as Pl A1 , the expression of which is controlled by a Leu33Pro substitution within the PSI domain at the N-terminus of GPIIIa. We have previously shown that disruption of the long-range Cys 5 -Cys 435 disulfide bond results in the production of GPIIIa isoforms that bind some, but not all, anti-Pl A1 alloantibodies, suggesting that mutations in this long-range disulfide bond can alter the conformation of GPIIIa. This substitution also resulted in the loss of the epitope for certain LIBS monoclonal antibodies as reported here and previously 43 , consistent with the data that some LIBS antibodies recognize epitopes within the EGF domains of GPIIIa 6 . Since the Cys 5 -Cys 435 disulfide bridge of GPIIIa connects the PSI domain to a region immediately amino terminal to the cysteine-rich EGF repeat region of GPIIIa, and brings the N-terminal region and the EGF domains of GPIIIa into physical proximity, this disulfide bridge may have the potential to regulate the shape of the ligand-binding pocket, and thereby affect the affinity of GPIIb-IIIa for its ligands. In the crystal structure, the 3 -subunit "knee" region is formed from the conjunction of the hybrid domain, EGF domains 1+2, and the PSI domain, and capable of extreme flexibility. Consistent with this, our studies provide functional confirmation for the presence of a long-range disulfide bond between Cys 5 -Cys 435 15 , and support the notion that this loop participates in conformational changes associated with receptor activation.
GPIIb-IIIa has been reported to contain endogenous thiol isomerase activity, predicted from the presence of the tetrapeptide motif, CXXC, in each of the EGF domains of 3 17 . This motif comprises the active site in enzymes involved in disulfide exchange reactions. Thiol isomerase activity within GPIIb-IIIa is inhibited by the protein-disulfide isomerase (PDI) inhibitor, bacitracin. Blocking PDI with bacitracin inhibits integrinmediated platelet adhesion regardless of the affinity state of the integrin. These data suggest that disulfide exchange takes place during integrin-mediated platelet adhesion 18 and altered thiol bonding within the integrin or its substrates may be locally modified during GPIIb-IIIa activation. Although all of cysteines within GPIIIa were previously thought to form disulfide bonds that stabilize the overall three-dimensional structure, these studies suggest that the GPIIIa EGF domains may contain unpaired cysteines that exhibit the properties of a redox site involved in integrin activation 16 . Modification of free cysteines within GPIIb-IIIa on the platelet surface prevents activation-dependent platelet aggregation 16 , and activated state of GPIIb-IIIa is converted to a resting conformation by incubation with a mixture of sodium nitroprusside (SNP) and reduced glutathione (GSH) 16 . In the constitutively active forms of After washing, cell adhesion was performed as described above. 
